Core Laboratories (CLB) Q1 Earnings and Revenues Lag Estimates

Core Laboratories Earnings Summary - Core Laboratories reported quarterly earnings of $0.14 per share, missing the Zacks Consensus Estimate of $0.15 per share, and down from $0.19 per share a year ago, representing an earnings surprise of -6.67% [1] - The company posted revenues of $123.59 million for the quarter, missing the Zacks Consensus Estimate by 0.38%, and down from $129.64 million year-over-year [2] - Over the last four quarters, Core Laboratories has surpassed consensus EPS estimates only once and has topped consensus revenue estimates just once [2] Stock Performance and Outlook - Core Laboratories shares have declined approximately 28.1% since the beginning of the year, compared to a decline of -10.1% for the S&P 500 [3] - The company's earnings outlook is currently unfavorable, leading to a Zacks Rank 4 (Sell), indicating expected underperformance in the near future [6] - The current consensus EPS estimate for the upcoming quarter is $0.18 on revenues of $127.62 million, and for the current fiscal year, it is $0.76 on revenues of $508.9 million [7] Industry Context - The Oil and Gas - Field Services industry, to which Core Laboratories belongs, is currently ranked in the top 35% of over 250 Zacks industries, suggesting a relatively strong industry performance [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact investor decisions [5]